Bile salt transporters: Molecular characterization, function, and regulation

Physiological Reviews

Volumn 83, Issue 2, 2003, Pages 633-671

  Trauner, Michael ^b   Boyer, James L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE CHLORIDE ANTIPORTER; BILE SALT; CANALICULAR BILE SALT EXPORT PUMP; CARRIER PROTEIN; HORMONE RECEPTOR; ILEAL SODIUM DEPENDENT BILE SALT TRANSPORTER; LIGAND; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; ORGANIC ANION TRANSPORTING PROTEIN; SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

BILE FLOW; CHOLESTASIS; ENTEROHEPATIC CIRCULATION; HEPATOBILIARY SYSTEM; KIDNEY PROXIMAL TUBULE; LIVER PROTECTION; LIVER REGENERATION; PLACENTA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION;

EID: 0037379362     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.00027.2002     Document Type: Review

References (400)

1. ABE T, KAKYO M, SAKAGAMI H, TOKUI T, NISHIO T, TANEMOTO M, NOMURA H, HEBERT SC, MATSUNO S, KONDO H, AND YAWO H. Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2. J Biol Chem 273: 22395- 22401, 1998.
2. ABE T, KAKYO M, TOKUI T, NAKAGOMI R, NISHIO T, NAKAI D, NOMURA H, UNNO M, SUZUKI M, NAITOH T, MATSUNO S, AND YAWO H. Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem 274: 17159-17163, 1999.
3. ACTON S, RIGOTTI A, LANDSCHULZ KT, XU S, HOBBS HH, AND KRIEGER M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271: 518-520, 1996.
4. AGELLON LB AND TORCHIA EC. Intracellular transport of bile acids. Biochim Biophys Acta 1486: 198-209, 2000.
5. AKITA H, SUZUKI H, HIROHASHI T, TAKIKAWA H, AND SUGIYAMA Y. Transport activity of human MRP3 expressed in Sf9 cells: comparative studies with rat MRP3. Pharm Res 19: 34-41, 2002.
6. AKITA H, SUZUKI H, AND SUGIYAMA Y. Sinusoidal efflux of taurocholate is enhanced in Mrp2-deficient rat liver. Pharm Res 18: 1119-1125, 2001.
7. ALPINI G, BAIOCCHI L, GLASER S, UENO Y, MARZIONI M, FRANCIS H, PHINIZY JL, ANGELICO M, AND LESAGE G. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha. Hepatology 35: 1041- 1052, 2002.
8. +-dependent bile acid transporter in large but not small rat cholangiocytes. Gastroenterology 113: 1734-1740, 1997.
9. ALPINI G, GLASER SS, UENO Y, RODGERS R, PHINIZY JL, FRANCIS H, BAIOCCHI L, HOLCOMB LA, CALIGIURI A, AND LESAGE GD. Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. Gastroenterology 116: 179-186, 1999.
10. ALPINI G, UENO Y, GLASER SS, MARZIONI M, PHINIZY JL, FRANCIS H, AND LESAGE G. Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes. Hepatology 34: 868-876, 2001.
11. ALVES C, VONDIPPE P, AMOUI M, AND LEVY D. Bile acid transport into hepatocyte smooth endoplasmic reticulum vesicles is mediated by microsomal epoxide hydrolase, a membrane protein exhibiting two distinct topological orientations. J Biol Chem 268: 20148-20155, 1993.
12. AMELSBERG A, JOCHIMS C, RICHTER CP, NITSCHE R, AND FOLSCH UR. Evidence for an anion exchange mechanism for uptake of conjugated bile acid from the rat jejunum. Am J Physiol Gastrointest Liver Physiol 276: G737-G742, 1999.
13. ANANTHANARAYANAN M, BALASUBRAMANIAN N, MAKISHIMA M, MANGELSDORF DJ, AND SUCHY FJ. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem 276: 28857-28865, 2001.
14. +-bile acid cotransporter using peptide and fusion protein antibodies. Am J Physiol Gastrointest Liver Physiol 267: G637-G643, 1994.
15. ANDERSON JM. Leaky junctions and cholestasis: a tight correlation. Gastroenterology 110: 1662-1665, 1996.
16. ANGELETTI RH, NOVIKOFF PM, JUUVADI SR, FRITSCHY JM, MEIER PJ, AND WOLKOFF AW. The choroid plexus epithelium is the site of the organic anion transport protein in the brain. Proc Natl Acad Sci USA 94: 283-286, 1997.
17. ARANDA A AND PASCUAL A. Nuclear hormone receptors and gene expression. Physiol Rev 81: 1269-1304, 2001.
18. ARAYA Z AND WIKVALL K. 6α-Hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes. Biochim Biophys Acta 1438: 47-54, 1999.
19. ARRESE M, ANANTHANARAYANAN M, AND SUCHY FJ. Hepatobiliary transport: molecular mechanisms of development and cholestasis. Pediatr Res 44: 141-147, 1998.
20. ARRESE M, TRAUNER M, SACCHIERO RJ, CROSSMAN MW, AND SHNEIDER B. Neither intestinal sequestration of bile acids nor common bile duct ligation modulate the expression and function of the rat ileal bile acid transporter. Hepatology 28: 1081-1087, 1998.
21. BACHS L, ELENA M, PARES A, PIERA C, AND RODES J. Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. The Lancet 1: 574-576, 1989.
22. BAIOCCHI L, LESAGE G, GLASER S, AND ALPINI G. Regulation of cholangiocyte bile secretion. J Hepatol 31: 179-191, 1999.
23. BALLATORI N, REBBEOR JF, CONNOLLY GC, SEWARD DJ, LENTH BE, HENSON JH, SUNDARAM P, AND BOYER JL. Bile salt excretion in skate liver is mediated by a functional analog of Bsep/Spgp, the bile salt export pump. Am J Physiol Gastrointest Liver Physiol 278: G57-G63, 2000.
24. BEIGNEUX AP, MOSER AH, SHIGENAGA JK, GRUNFELD C, AND FEINGOLD KR. The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem 275: 16390-16399, 2000.
25. BENEDETTI A, DISARIO A, MARUCCI L, SVEGLIATI-BARONI G, SCHTEIN-GART CD, TON-NU HT, AND HOFMANN AF. Carrier-mediated transport of conjugated bile acids across the basolateral membrane of biliary epithelial cells. Am J Physiol Gastrointest Liver Physiol 272: G1416-G1424, 1997.
26. BERGE KE, TIAN H, GRAF GA, YU L, GRISHIN NV, SCHULTZ J, KWITEROVICH P, SHAN B, BARNES R, AND HOBBS HH. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290: 1771-1775, 2000.
27. BERGEN AA, PLOMP AS, SCHUURMAN EJ, TERRY S, BREUNING M, DAUWERSE H, SWART J, KOOL M, VANSOEST S, BAAS F, TENBRINK JB, AND DEJONG PT. Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet 25: 228-231, 2000.
28. BERGWERK AJ, SHI X, FORD AC, KANAI N, JACQUEMIN E, BURK RD, BAI S, NOVIKOFF PM, STIEGER B, MEIER PJ, SCHUSTER VL, AND WOLKOFF AW. Immunologic distribution of an organic anion transport protein in rat liver and kidney. Am J Physiol Gastrointest Liver Physiol 271: G231-G238, 1996.
29. BEUERS U, BILZER M, CHITTATTU A, KULLAK-UBLICK GA, KEPPLER D, PAUMGARTNER G, AND DOMBROWSKI F. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology 33: 1206-1216, 2001.
30. 2+ signals in isolated rat hepatocytes. Gastroenterology 104: 604-612, 1993.
31. 2+ mechanisms defective in cholestasis. J Clin Invest 92: 2984-2993, 1993.
32. BEUERS U, PROBST I, SOROKA C, BOYER JL, KULLAK-UBLICK GA, AND PAUMGARTNER G. Modulation of protein kinase C by taurolithocholic acid in isolated rat hepatocytes. Hepatology 29: 477-482, 1999.
33. BEUERS U, THROCKMORTON DC, ANDERSON MS, ISALES CM, THASLER W, KULLAK-UBLICK GA, SAUTER G, KOEBE HG, PAUMGARTNER G, AND BOYER JL. Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. Gastroenterology 110: 1553-1563, 1996.
34. BODZIOCH M, ORSO E, KLUCKEN J, LANGMANN T, BOTTCHER A, DIEDERICH W, DROBNIK W, BARLAGE S, BUCHLER C, PORSCH-OZCURUMEZ M, KAMINSKI WE, HAHMANN HW, OETTE K, ROTHE G, ASLANIDIS C, LACKNER KJ, AND SCHMITZ G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22: 347-351, 1999.
35. BOHAN A AND BOYER JL. Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions. Semin Liver Dis 22: 123-136, 2002.
36. BOHAN A, DENSON LA, BAJWA J, HELD MA, AND BOYER JL. Reciprocal alterations in nuclear hormone receptor (NHR) expression may explain organ specific changes in bile salt synthesis and transport in the cholestatic rat (Abstract). Hepatology 34: 261A, 2001.
37. BORST P, EVERS R, KOOL M, AND WIJNHOLDS J. The multidrug resistance protein family. Biochim Biophys Acta 1461: 347-357, 1999.
38. BOYER JL. New concepts of mechanisms of hepatocyte bile formation. Physiol Rev 60: 303-326, 1980.
39. BOYER JL. Bile duct epithelium: frontiers in transport physiology. Am J Physiol Gastrointest Liver Physiol 270: G1-G5, 1996.
40. BOYER JL. Advancing the bile-ology of cholestatic liver disease. Hepatology 33: 758-759, 2001.
41. BOYER JL. Molecular pathophysiology of membrane transport function in cholestasis. In: The Liver: Biology and Pathobiology, edited by Arias IM, Boyer JL, Chisari FV, Fausto N, Schachter D, and Shafritz DA. Philadelphia, PA: Lippincott Williams & Wilkins, 2001, p. 663-677.
42. BOYER JL. Milestones in liver disease: a commentary. J Hepatol 36: 4-7, 2002.
43. BOYER JL, HAGENBUCH B, ANANTHANARAYANAN M, SUCHY F, STIEGER B, AND MEIER PJ. Phylogenic and ontogenic expression of hepatocellular bile acid transport. Proc Natl Acad Sci USA 90: 435-438, 1993.
44. BOYER JL AND NATHANSON MH. Bile formation. In: Schiffs Diseases of the Liver, edited by Schiff ER, Sorrell MF, and Maddrey WC. New York: Lippincott-Raven, 1999, p. 119-146.
45. BOYER JL AND SOROKA CJ. Vesicle targeting to the apical domain regulates bile excretory function in isolated rat hepatocyte couplets. Gastroenterology 109: 1600-1611, 1995.
46. BRAVO P, MARIN JJ, BEVERIDGE MJ, AND NOVAX DA. Reconstitution and characterization of ATP-dependent bile acid transport in human and rat placenta. Biochem J 311: 479-485, 1995.
47. BREMMELGAARD A AND SJOVALL J. Bile acid profiles in urine of patients with liver diseases. Eur J Clin Invest 9: 341-348, 1979.
48. BROOKS-WILSON A, MARCIL M, CLEE SM, ZHANG LH, ROOMP K, VAN DAM M, YU L, BREWER C, COLLINS JA, MOLHUIZEN HO, LOUBSER O, OUELETTE BF, FICHTER K, ASHBOURNE-EXCOFFON KJ, SENSEN CW, SCHERER S, MOTT S, DENIS M, MARTINDALE D, FROHLICH J, MORGAN K, KOOP B, PIMSTONE S, KASTELEIN JJ, AND HAYDEN MR. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22: 336-345, 1999.
49. BUECHLER M, KOENIG J, BROM M, KARTENBECK J, SPRING H, HORIE T, AND KEPPLER D. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem 271: 15091-15098, 1996.
50. BULL LN, VAN EIJK MJT, PAWLIKOWSKA L, DEYOUNG JA, JUIJN JA, LIAO M, KLOMP LW, LOMRI N, BERGER R, SCHARSCHMIDT BF, KNISELY AS, HOUWER RH, AND FREIMER NS. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 18: 219-224, 1998.
51. BUSCHER HP, MEDER I, MACNELLY S, AND GEROK W. Zonal changes of hepatobiliary taurocholate transport in intrahepatic cholestasis induced by 17α-ethinyl estradiol: a histoautoradiographic study in rats. Hepatology 17: 494-499, 1993.
52. BYRNE J, SOLER E, STRAUTNIEKS S, AND THOMPSON R. Genetic Analysis of Progressive Familial Intrahepatic Cholestasis, edited by van Berge-Henegouwen GP, Keppler D, Leuschner U, Paumgartner G, and Stiehl A. Dordrecht, The Netherlands: Kluwer Academic, 2000, p. 288-300. (Falk Symposium 120)
53. BYRNE JA, STRAUTNIEKS SS, MIELI-VERGANI G, HIGGINS CF, LINTON KJ, AND THOMPSON RJ. The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. Gastro 123: 1649-1658, 2003.
54. CAI SY, WANG L, BALLATORI N, AND BOYER JL. Bile salt export pump is highly conserved during vertebrate evolution and its expression is inhibited by PFIC type II mutations. Am J Physiol Gastrointest Liver Physiol 281: G316-G322, 2001.
55. CAI SY, WANG W, SOROKA CJ, BALLATORI N, AND BOYER JL. An evolutionarily ancient Oatp: insights into conserved functional domains of these proteins. Am J Physiol Gastrointest Liver Physiol 282: G702-G710, 2002.
56. CANCADO EL, LEITAO RM, CARRILHO FJ, AND LAUDANNA AA. Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gamma-glutamyl transpeptidase. Am J Gastroenterol 93: 1510-1517, 1998.
57. CATTORI V, ECKHARDT U, AND HAGENBUCH B. Molecular cloning and functional characterization of two alternatively spliced Ntcp isoforms from mouse liver1. Biochim Biophys Acta 1445: 154-159, 1999.
58. CATTORI V, HAGENBUCH B, HAGENBUCH N, STIEGER B, HA R, WINTER-HALTER KE, AND MEIER PJ. Identification of organic anion transporting polypeptide 4 (Oatp4) as a major full-length isoform of the liver-specific transporter-1 (rlst-1) in rat liver. FEBS Lett 474: 242-245, 2000.
59. CATTORI V, VAN MONTFOORT JE, STIEGER B, LANDMANN L, MEIJER DKF, WINTERHALTER KH, MEIER PJ, AND HAGENBUCH B. Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3. Pflügers Arch 443: 188-195, 2001.
60. CEREGHINI S. Liver-enriched transcription factors and hepatocyte differentiation. FASEB J 10: 267-282, 1996.
61. CHAWLA A, REPA JJ, EVANS RM, AND MANGELSDORF DJ. Nuclear receptors and lipid physiology: opening the X-files. Science 294: 1866-1870, 2001.
62. CHAWLA A, SAEZ E, AND EVANS RM. "Don't know much bile-ology." Cell 103: 1-4, 2000.
63. CHEN F, MA L, ANANTHANARAYANAN M, SINAL C, DAWSON P, MANGELS-DORF D, GONZALEZ F, AND SHNEIDER BL. Negative-feedback regulation of the ileal apical sodium-dependent bile acid transporter (ASBT) is mediated by the Farnesoid X-Receptor (FXR) (Abstract). Gastroenterology 122: A-625, 2002.
64. CHEN HL, CHANG PS, HSU HC, LEE JH, NI YH, HSU HY, JENG YM, AND CHANG MH. Progressive familial intrahepatic cholestasis with high gamma-glutamyltranspeptidase levels in Taiwanese infants: role of MDR3 gene defect? Pediatr Res 50: 50-55, 2001.
65. CHERRINGTON NJ, HARTLEY DP, LI N, JOHNSON DR, AND KLAASSEN CD. Organ distribution of multidrug resistance proteins 1, 2, and 3 (mrp1, 2, and 3) mRNA and hepatic induction of mrp3 by constitutive androstane receptor activators in rats. J Pharmacol Exp Ther 300: 97-104, 2002.
66. CHIANG JYL. Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev 23: 443-463, 2002.
67. CHIGNARD N, MERGEY M, VEISSIERE D, PARC R, CAPEAU J, POUPON R, PAUL A, AND HOUSSET C. Bile acid transport and regulating functions in the human biliary epithelium. Hepatology 33: 496-503, 2001.
68. CHILDS S, YEH RL, GEORGES E, AND LING V. Identification of a sister gene to p-glycoprotein. Cancer Res 55: 2029-2034, 1995.
69. CHILDS S, YEH RL, HUI D, AND LING V. Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein. Cancer Res 58: 4160-4167, 1998.
70. CHOUDHURI S, OGURA K, AND KLAASSEN CD. Cloning of the full-length coding sequence of rat liver-specific organic anion transporter-1 (rlst-1) and a splice variant and partial characterization of the rat lst-1 gene. Biochem Biophys Res Commun 274: 79-86, 2000.
71. CHRISTIE DM, DAWSON PA THEVANANTHER S, AND SHNEIDER BL. Comparative analysis of the ontogeny of a sodium-dependent bile acid transporter in rat kidney and ileum. Am J Physiol Gastrointest Liver Physiol 271: G377-G385, 1996.
72. CLAYTON RJ, IBER FL, RUEBNER BH, AND MCKUSICK VA. Byler Disease: fatal familial intrahepatic cholestasis in an Amish Kindred. Am J Dis Child 117: 112-124, 1969.
73. COLE SP, BHARDWAJ G, GERLACH JH, MACKIE JE, GRANT CE, ALMQUIST KC, STEWART AJ, KURZ EU, DUNCAN AM, AND DEELEY RG. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654, 1992.
74. CRADDOCK AL, LOVE MW, DANIEL RW, KIRBY LC, WALTERS HC, WONG MH, AND DAWSON PA. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol Gastrointest Liver Physiol 278: G157-G169, 1998.
75. CUI J, HEARD TS, YU J, LO JL, HUANG L, Li Y, SCHAEFFER JM, AND WRIGHT SD. The amino acid residues asparagine 354 and isoleucine 372 of human farnesoid X receptor confer the receptor with high sensitivity to chenodeoxycholate. J Biol Chem 277: 25963-25969, 2002.
76. CUI Y, KONIG J, BUCHHOLZ JK, SPRING H, LEIER I, AND KEPPLER D. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol 55: 929-937, 1999.
77. CUI Y, KONIG J, AND KEPPLER D. Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol Pharmacol 60: 934-943, 2001.
78. CUI Y, KONIG J, LEIER I, BUCHHOLZ U, AND KEPPLER D. Hepatic uptake of bilirubin and its conjugates by the human organic anion-transporter SLC21A6. J Biol Chem 276: 9626-9630, 2001.
79. DAWSON PA AND OELKERS P. Bile acid transporters. Curr Opin Lipidol 6: 109-114, 1995.
80. DELEUZE JF, JACQUEMIN E, DUBUISSON C, CRESTELL D, DUMONT M, ERLINGER S, BERNARD O, AND HADCHOUEL M. Defect on multidrug- resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 23: 904-908, 1996.
81. DENSON LA, AULD KL, SCHIEK DS, MCCLURE MH, MANGELSDORF DJ, AND KARPEN SJ. Interleukin-1β suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J Biol Chem 275: 8835-8843, 2000.
82. DENSON LA, BOHAN A, BAJWA HJ, HELD MA, AND BOYER JL. Alterations in nuclear hormone receptors (NHR) are associated with changes in the expression of multidrug resistance proteins MRP2 and MRP3 in liver and kidney in cholestasis (Abstract). Hepatology 34: 264A, 2001.
83. DENSON LA, BOHAN A, HELD MA, AND BOYER JL. Organ-specific alterations in RARα: RXRα abundance regulate rat Mrp2 (Abcc2) expession in obstructive cholestasis. Gastroenterology 123: 599-607, 2002.
84. +-dependent bile acid cotransporter. Am J Physiol Gastrointest Liver Physiol 279: G347-G355, 2000.
85. DENSON LA, STURM E, ECHEVARRIA W, ZIMMERMAN TL, MAKISHIMA M, MANGELSDORF DJ, AND KARPEN SJ. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 121: 140-147, 2001.
86. DE VREE JM, OTTENHOFF R, BOSMA PJ, SMITH AJ, ATEN J, AND ELFERINK RP. Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 119: 1720-1730, 2000.
87. DEVREE JML, JACQUEMIN E, STURM E, CRESTIL D, BOSMA PJ, ALTEN J, DELEUZE JF, DESROCHERS M, BURDELSKI M, BERNARD O, OUDE ELF- ERINK RP, AND HADCHOUEL M. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 95: 282-287, 1998.
88. DEVREE JML, ROMIJN JA, MOK KS, MATHUS-VLIEGEN LM, STOUTENBEEK CP, OSTROW JD, TYTGAT GN, SAUERWEIN HP, OUDE ER, AND GROEN AK. Lack of enteral nutrition during critical illness is associated with profound decrements in biliary lipid concentrations. Am J Clin Nutr 70: 70-77, 1999.
89. DONNER MG AND KEPPLER D. Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology 34: 351-359, 2001.
90. DRANOFF JA, MCCLURE M, BURGSTAHLER AD, DENSON LA, CRAWFORD AR, CRAWFORD JM, KARPEN SJ, AND NATHANSON MH. Short-term regulation of bile acid uptake by microfilament-dependent translocation of rat ntcp to the plasma membrane. Hepatology 30: 223-229, 1999.
91. +-independent organic anion transporting polypeptide (oatp) in rat liver and kidney. J Hepatol 25: 932-940, 1996.
92. 2 purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol Cell Physiol 265: C577-C606, 1993.
93. DUMOULIN FL, REICHEL C, SAUERBRUCH T, AND SPENGLER U. Semiquantitation of intrahepatic MDR3 mRNA levels by reverse transcription/competitive polymerase chain reaction. J Hepatol 26: 852-856, 1997.
94. EJENDAL HRYCYNA CA. Multidrug resistance and cancer: the role of the human ABC transporter ABCG2. Curr Opin Cell Biol 3: 503- 511, 2002.
95. ELFERINK MG, OLINGA P, MEREMA MT, MUELLER M, SLOOFF M, AND MEIJER DK. Perturbation of NTCP, BSEP and MRP2 in human liver slices exposed to LPS (Abstract). Hepatology 32: A1075, 2000.
96. EPPENS EF, VAN MIL SWC, DE VREE JML, MOK KS, JUIJN JA, OUDE ELFERINK RPJ, BERGER R, HOUWEN RHJ, AND KLOMP LWJ. FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte. J Hepatol 35: 436-443, 2001.
97. FATTINGER K, FUNK C, PANTZE M, WEBER C, REICHEN J, STIEGER B, AND MEIER PJ. The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions. Clin Pharmacol Ther 69: 223-231, 2001.
98. FELDMAN G. The cytoskeleton of the hepatocyte. J Hepatol 8: 380-386, 1989.
99. FICKERT P, ZOLLNER G, FUCHSBICHLER A, STUMPTNER C, POJER C, ZENZ R, LAMMERT F, STIEGER B, MEIER PJ, ZATLOUKAL K, DENK H, AND TRAUNER M. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 121: 170-183, 2001.
100. a. FICKERT P, ZOLLNER G, FUCHSBICHLER A, STUMPTNER C, WEIGLEIN AH, LAMMERT F, MARSHALL HU, TSYBROVSKYY O, ZATLOUKAL K, DENK H, AND TRAUNER M. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 123: 1238-1251, 2002.
101. FORKER EL, LUXON BA, SNELL M, AND SHURMANTINE WO. Effect of albumin binding on the hepatic transport of rose bengal: surface-mediated dissociation of limited capacity. J Pharmacol Exp Ther 223: 342-347, 1982.
102. FRITZ F, CHEN J, HAYES P, AND SIROTNAK FM. Molecular cloning of the murine cMOAT ATPase. Biochim Biophys Acta 1492: 531-536, 2000.
103. FUNK C, PONELLE C, SCHEUERMANN G, AND PANTZE M. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. Mol Pharmacol 59: 627-635, 2001.
104. GANGULY TC, O'BRIEN ML, KARPEN SJ, HYDE JF, SUCHY FJ, AND VORE M. Regulation of the rat liver sodium-dependent bile acid cotransporter gene by prolactin. J Clin Invest 99: 2906-2914, 1997.
105. GAO B, HAGENBUCH B, KULLAK-UBLICK GA, BENKE D, AGUZZI A, AND MEIER PJ. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J Pharmacol Exp Ther 294: 73-79, 2000.
106. GAO B, STIEGER B, NOE B, FRITSCHY JM, AND MEIER PJ. Localization of the organic anion transporting polypeptide 2 (oatp2) in capillary endothelium and choroid plexus epithelium of rat brain. J Histochem Cytochem 47: 1255-1264, 1999.
107. +/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology 110: 199-209, 1996.
108. GARTUNG C AND MATERN S. Molecular regulation of organic anion transport in cholestasis. In: Cholestatic Liver Diseases, edited by Manns M, Boyer JL, Jansen PLM, and Reichen J. Dordrecht, The Netherlands: Kluwer Academic, 1998, p. 21-28. (Falk Symposium 102)
109. +/taurocholate cotransporter is regulated in vivo by retention of biliary constituents but not their depletion. Hepatology 25: 284-290, 1997.
110. GATMAITAN ZC, NIES AT, AND ARIAS IM. Regulation and translocation of ATP-dependent apical membrane proteins in rat liver. Am J Physiol Gastrointest Liver Physiol 272: G1041-G1049, 1997.
111. GERLOFF T, GEIER A, ROOTS I, MEIER PJ, AND GARTUNG C. Functional analysis of the rat bile salt export pump gene promoter. Eur J Biochem 269: 3495-3503, 2002.
112. GERLOFF T, GEIER A, STIEGER B, HAGENBUCH B, MEIER PJ, MATERN S, AND GARTUNG C. Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver. Gastroenterology 117: 1408-1415, 1999.
113. GERLOFF T, STIEGER B, HAGENBUCH B, MADON J, LANDMANN L, ROTH J, HOFMANN AF, AND MEIER PJ. The sister P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 273: 10046-10050, 1998.
114. GIGLIOZZI A, FRAIOLI F, SUNDARAM P, LEE J, MENNONE A, ALVARO D, AND BOYER JL. Molecular identification and functional characterization of mdr1a in rat cholangiocytes. Gastroenterology 119: 1113-1122, 2000.
115. GLAVY JS, WU SM, WANG PJ, ORR GA, AND WOLKOFF AW. Down- regulation by extracellular ATP of rat hepatocyte organic anion transport is mediated by serine phosphorylation of oatp1. J Biol Chem 275: 1479-1484, 2000.
116. GONG YZ, EVERETT ET, SCHWARTZ DA, NORRIS JS, AND WILSON FA. Molecular cloning, tissue distribution, and expression of a 14-kDa bile acid-binding protein from rat ileal cytosol. Proc Natl Acad Sci USA 91: 4741- 4745, 1994.
117. GOODWIN B, JONES SA, PRICE RR, WATSON MA, MCKEE DD, MOORE LB, GALARDI C, WILSON JG, LEWIS MC, ROTH ME, MALONEY PR, WILLSON TM, AND KLIEWER SA. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6: 517-526, 2000.
118. GREEN RM, HODA F, AND WARD KL. Molecular cloning and characterization of the murine bile salt export pump. Gene 241: 117-123, 2000.
119. GROBER J, ZAGHINI I, FUJII H, JONES SA, KLIEWER SA, WILLSON TM, ONO T, AND BESNARD P. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer. J Biol Chem 274: 29749-29754, 1999.
120. GROOTHUIS GM, HARDONK MJ, KEULEMANS KP, NIEUWENHUIS P, AND MEIJER DK. Autoradiographic and kinetic demonstration of acinar heterogeneity of taurocholate transport. Am J Physiol Gastrointest Liver Physiol 243: G455-G462, 1982.
121. +/taurocholate cotransport by cyclic AMP. J Biol Chem 268: 17734-17741, 1993.
122. GUO GL, CHOUDHURI S, AND KLAASSEN CD. Induction profile of rat organic anion transporting polypeptide 2 (oatp2) by prototypical drug-metabolizing enzyme inducers that activate gene expression through ligand-activated transcription factor pathways. Pharmacol Exp Ther 300: 206-212, 2002.
123. GUPTA S, STRAVITZ RT, DENT P, AND HYLEMON PB. Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N- terminal kinase pathway. J Biol Chem 276: 15816-15822, 2001.
124. GURANTZ D, SCHTEINGART CD, HAGEY LR, STEINBACH JH, GROTMOL T, AND HOFMANN AF. Hypercholeresis induced by unconjugated bile acid infusion correlates with recovery in bile of unconjugated bile acids. Hepatology 13: 540-550, 1991.
125. HAGENBUCH B, ADLER ID, AND SCHMID TE. Molecular cloning and functional characterization of the mouse organic-anion-transporting polypeptide 1 (Oatp1) and mapping of the gene to chromosome X. Biochem J 345: 115-120, 2000.
126. +/ bile acid cotransporter. J Clin Invest 93: 1326-1331, 1994.
127. HAGENBUCH B, SCHARSCHMIDT BF, AND MEIER PJ. Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes. Biochem J 216: 901-904, 1996.
128. +/bile acid cotransport system. Proc Natl Acad Sci USA 88: 10629-10633, 1991.
129. HAGENBUCH N, REICHEL C, STIEGER B, CATTORI V, FATTINGER KE, LANDMANN L, MEIER PJ, AND KULLAK-UBLICK GA. Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver. J Hepatol 34: 881-887, 2001.
130. HALLEN S, BRÄNDEN M, DAWSON P, AND SACHS G. Membrane insertion scanning of the human ileal sodium/bile acid co-transporter. Biochemistry 38: 11379-11388, 1999.
131. HAUSSINGER D, SCHMITT M, WEIERGRABER O, AND KUBITZ R. Short-term regulation of canalicular transport. Semin Liver Dis 20: 307-321, 2000.
132. HAYAKAWA T, BRUCK R, NG OC, AND BOYER JL. DBcAMP stimulates vesicle transport and HRP excretion in isolated perfused rat liver. Am J Physiol Gastrointest Liver Physiol 259: G727-G735, 1990.
133. HAYAKAWA T, NG OC, MA A, AND BOYER JL. Taurocholate stimulates transcytotic vesicular pathways labelled by horseradish peroxidase in the isolated perfused rat liver. Gastroenterology 99: 216-228, 1990.
134. HAYHURST GP, LEE YH, LAMBERT G, WARD JM, AND GONZALEZ FJ. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 21: 1393-1403, 2001.
135. HIRANO F, TANADA H, MAKINO Y, OKAMOTO K, HIRAMOTO M, HANDA H, AND MAKINO I. Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids. Carcinogenesis 17: 427-433, 1996.
136. HIROHASHI T, SUZUKI H, CHU XY, TAMAI I, TSUJI A, AND SUGIYAMA Y. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). J Pharmacol Exp Ther 292: 265-270, 2000.
137. HIROHASHI T, SUZUKI H, ITO K, OGAWA K, KUME K, SHIMIZU T, AND SUGIYAMA Y. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in Eisai hyperbilirubinemic rats. Mol Pharmacol 53: 1068-1075, 1998.
138. HIROHASHI T, SUZUKI H, AND SUGIYAMA Y. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J Biol Chem 274: 15181-15185, 1999.
139. HIROHASHI T, SUZUKI H, TAKIKAWA H, AND SUGIYAMA Y. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). J Biol Chem 275: 2905-2910, 2000.
140. HOFMANN AF. Bile acids: the good, the bad and the ugly. News Physiol Sci 14: 24-29, 1999.
141. HOOIVELD GJ, VAN MONTFOORT JE, MEIJER DK, AND MULLER M. Function and regulation of ATP-binding cassette transport proteins involved in hepatobiliary transport. Eur J Pharm Sci 12: 525-543, 2001.
142. HORVATH CM AND DARNELL JE. The state of the STATs: recent developments in the study of signal transduction to the nucleus. Curr Opin Cell Biol 9: 233-239, 1997.
143. HSIANG B, ZHU Y, WANG Z, WU Y, SASSEVILLE V, YANG WP, AND KIRCHGESSNER TG. A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J Biol Chem 274: 37161-37168, 1999.
144. HUANG L AND VORE M. Multidrug resistance P-glycoprotein 2 is essential for the biliary excretion of indocyanine green. Drug Metab Dispos 29: 634-637, 2001.
145. HUBACEK JA, BERGE KE, COHEN JC, AND HOBBS HH. Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia. Hum Mutat 18: 359-360, 2001.
146. HWANG ST AND HENNING SJ. Hormonal regulation of expression of ileal bile acid binding protein in suckling rats. Am J Physiol Regul Integr Comp Physiol 278: R1555-R1563, 2000.
147. ILIAS A, URBAN Z, SEIDL TL, LE SAUX O, SINKO E, BOYD CD, SARKADI B, AND VARADI A. Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J Biol Chem 277: 16860-16867, 2002.
148. INOKUCHI A, HINOSHITA E, IWAMOTO Y, KOHNO K, KUWANO M, AND UCHIUMI T. Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporter. J Biol Chem 276: 46822-46829, 2001.
149. ISMAIR MG, STIEGER B, CATTORI V, HAGENBUCH B, FRIED M, MEIER PJ, AND KULLAK-UBLICK GA. Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides Oatp4 and OATP8 of rat and human liver. Gastroenterology 121: 1185-1190, 2001.
150. ITO K, SUZUKI H, AND SUGIYAMA Y. Single amino acid substitution of rat MRP2 results in acquired transport activity for taurocholate. Am J Physiol Gastrointest Liver Physiol 281: G1034-G1043. 2001.
151. JACQUEMIN E, CRESTEIL D, MANOUVRIER S, BOUTE O, AND HADCHOUEL M.
152. JACQUEMIN E, DE VREE JM, CRESTEIL D, SOKAL EM, STURM E, DUMONT M, SCHEFFER GL, PAUL M, BURDELSKI M, BOSMA PJ, BERNARD O, HADCHOUEL M, AND OUDE ELFERINK RPJ. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 120: 1448-1458, 2001.
153. +-independent organic anion transporter. Proc Natl Acad Sci USA 91: 133-137, 1994.
154. JANSEN PL AND MULLER M. The molecular genetics of familial intrahepatic cholestasis. Gut 47: 1-5, 2000.
155. JANSEN PL, MULLER M, AND STURM E. Genes and cholestasis. Hepatology 34: 1067-1074, 2001.
156. JANSEN PL, STRAUTNIEKS SS, JACQUEMIN E, HADCHOUEL M, SOKAL EM, HOOIVELD GJ, KONING JH, DE JAGER-KRIKKEN A, KUIPERS F, STELLAARD F, BIJLEVELD CM, GOUW A, VAN GH, THOMPSON RJ, AND MULLER M. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 117: 1370-1379, 1999.
157. JANSEN PLM. Foreward: from classic bile physiology to cloned transporters. Semin Liver Dis 20: 245-250, 2000.
158. JANSEN PLM, PETERS WH, AND LAMERS WH. Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology 5: 573-579, 1985.
159. JI Y, WANG N, RAMAKRISHNAN R, SEHAYEK E, HUSZAR D, BRESLOW JL, AND TALL AR. Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J Biol Chem 274: 33398-33402, 1999.
160. JONES AL, HRADEK GT, RENSTON RH, WONG KY, KARLAGANIS G, AND PAUMGARTNER G. Autoradiographic evidence for hepatic lobular concentration gradient of bile acid derivative. Am J Physiol Gastrointest Liver Physiol 238: G233-G237, 1980.
161. JUNG D, FRIED M, AND KULLAK-UBLICK GA. Human apical sodium-dependent bile salt transporter gene (SLC10A2) is regulated by the peroxisome proliferator-activated receptor α. J Biol Chem 277: 30559-30566, 2002.
162. JUNG D, HAGENBUCH B, GRESH L, PONTOGLIO M, MEIER PJ, AND KULLAK-UBLICK GA. Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha. J Biol Chem 276: 37206-37214, 2001.
163. JUNG D, PODVINEC M, MEYER UA, MANGELSDORF DJ, FRIED M, MEIER PJ, AND KULLAK-UBLICK GA. Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor. Gastroenterology 122: 1954-1966, 2002.
164. KAKYO M, SAKAGAMI H, NISHIO T, NAKAI D, NAKAGOMI R, TOKUI T, NAITOH T, MATSUNO S, ABE T, AND YAWO H. Immunohistochemical distribution and functional characterization of an organic anion transporting polypeptide 2 (Oatp2). FEBS Lett 445: 343-346, 1999.
165. KAKYO M, UNNO M, TOKUI T, NAKAGOMI R, NISHIO T, IWASASHI H, NAKAI D, SEKI M, SUZUKI M, NAITOH T, MATSUNO S, YAWO H, AND ABE T. Molecular characterization and functional regulation of a novel rat liver-specific organic anion transporter rlst-1. Gastroenterology 117: 770-775, 1999.
166. KANDA T, FOUCAND L, NAKAMURA Y, NIOT I, BESNARD P, FUJITA M, SAKAI Y, HATAKEYAMA K, ONO T, AND FUJII H. Regulation of expression of human intestinal bile acid-binding protein in Caco-2 cells. Biochem J 330: 261-265, 1998.
167. KANDA T, NIOT I, FOUCAUD L, FUJII H, BERNARD A, ONO T, AND BESNARD P. Effect of bile on the intestinal bile-acid binding protein (I-BABP) expression. In vitro and in vivo studies. FEBS Lett 384: 131-134, 1996.
168. KANNO N, LESAGEG, GLASER S, AND ALPINI G. Regulation of cholangiocyte bicarbonate secretion. Am J Physiol Gastrointest Liver Physiol 281: G612-G625, 2001.
169. KANNO N, LESAGE G, GLASER S, ALVARO D, AND ALPINI G. Functional heterogeneity of the intrahepatic biliary epithelium. Hepatology 31: 555-561, 2000.
170. KARPEN SJ. Nuclear receptor regulation of hepatic function. J Hepatol 36: 832-850, 2002.
171. KARPEN SJ, SUN A, KUDISH B, HAGENBUCH B, MEIER PJ, ANANTHANARAYANAN M, AND SUCHY FJ. Multiple factors regulate the rat liver basolateral sodium-dependent bile acid cotransporter gene promoter. J Biol Chem 271: 15211-15221, 1996.
172. KARTENBECK J, LEUSCHNER U, MAYER R, AND KEPPLER D. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 23: 1061-1066, 1996.
173. KAST HR, GOODWIN B, TARR PT, JONES SA, ANISFELD AM, STOLTZ CM, TONTONOZ P, KLIEWER S, WILLSON TM, AND EDWARDS PA. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277: 2908-2915, 2002.
174. KAUFFMANN HM AND SCHRENK D. Sequence analysis and functional characterization of the 5′-flanking region of the rat multidrug resistance protein 2 (MRP2) gene. Biochem Biophys Res Commun 245: 325-331, 1998.
175. KAWAGUCHI T, SAKISAKA S, HARADA M, HANADA S, TANIGUCHI E, KOGA H, SASATOMI K, TANIKAWA K, AND SATA M. Endotoxin increases paracellular permeability of isolated rat hepatocyte couplets. Hepatol Res 20: 144-154, 2001.
176. KEIDING S, OTT P, AND BASS L. Enhancement of unbound clearance of ICG by plasma proteins, demonstrated in human subjects and interpreted without assumption of facilitating structures. J Hepatol 19: 327-344, 1993.
177. KEITEL V, KARTENBECK J, NIES AT, SPRING H, BROM M, AND KEPPLER D. Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in dubin-johnson syndrome. Hepatology 32: 1317-1328, 2000.
178. KEPPLER D AND ARIAS IM. Introduction: transport across the hepatocyte canalicular membrane. FASEB J 11: 15-18, 1997.
179. KEPPLER D, CUI Y, KONIG J, LEIER I, AND NIES A. Export pumps for anionic conjugates encoded by MRP genes. Adv Enzyme Regul 39: 237-246, 1999.
180. KEPPLER D AND KONIG J. Hepatic secretion of conjugated drugs and endogenous substances. Semin Liver Dis 20: 265-272, 2000.
181. KERR TA, SAEKI S, SCHNEIDER M, SCHAEFER K, BERDY S, REDDER T, SHAN B, RUSSELL DW, AND SCHWARZ M. Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev Cell 2: 713-720, 2002.
182. KIKUCHI S, HATA M, FUKUMOTO K, YAMANE Y, MATSUI T, TAMURA A, YONEMURA S, YAMAGISHI H, KEPPLER D, TSUKITA S, AND TSUKITA S. Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes. Nat Genet 31: 320-325, 2002.
183. KIPP H AND ARIAS IM. Trafficking of canalicular ABC transporters in hepatocytes. Annu Rev Physiol 64: 595-608, 2002.
184. KIPP H AND ARIAS IM. Intracellular trafficking and regulation of canalicular ATP-binding cassette transporters. Semin Liver Dis 20: 339-351, 2000.
185. KIPP H, PICHETSHOTE N, AND ARIAS IM. Transporters on demand: intrahepatic pools of canalicular ATP-binding cassette transporters in rat liver. J Biol Chem 276: 7218-7224, 2001.
186. KIUCHI Y, SUZUKI H, HIROHASHI T, TYSON CA, AND SUGIYAMA Y. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). FEBS Lett 433: 149-152, 1998.
187. KLOMP LW, BULL LN, KNISELY AS, VAN DER D, JUIJN JA, BERGER R, FORGET S, NIELSEN IM, EIBERG H, AND HOUWEN RH. A missense mutation in FIC1 is associated with greenland familial cholestasis. Hepatology 32: 1337-1341, 2000.
188. KOGAN D, ANANTHANARAYANAN M, EMRE S, SUCHY FJ, AND SHNEIDER BL. The bile salt excretory pump (BSEP/SPGP) is not down-regulated in human cholestasis associated with extrahepatic biliary atresia (EHBA) (Abstract). Hepatology 30: 468A, 1999.
189. KONIG J, CUI Y, NIES AT, AND KEPPLER D. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol Gastrointest Liver Physiol 278: G156-G164, 2000.
190. KONIG J, CUI Y, NIES AT, AND KEPPLER D. Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem 275: 23161-23168, 2000.
191. KONIG J, NIES AT, CUI Y, LEIER I, AND KEPPLER D. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1461: 377-394, 1999.
192. KONIG J, ROST D, CUI Y, AND KEPPLER D. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29: 1156-1163, 1999.
193. KOOL M, VAN DER LINDEN M, DE HAAS M, BAAS F, AND BORST P. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res 59: 175-182, 1999.
194. KOOL M, VAN DER LINDEN M, DEHAAS M, SCHEFFER GL, DE VREE JML, SMITH AJ, JANSEN G, PETERS GJ, PONNE N, SCHEPER RJ, OUDE ELFERINK RPJ, BAAS F, AND BORST P. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci USA 96: 6914-6919, 1999.
195. KOZARSKY KF, DONAHEE MH, RIGOTTI A, IQBAL SN, EDELMAN ER, AND KRIEGER M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 387: 414-417, 1997.
196. +/bile acid co-transport system from rabbit ileum. Biochem J 306: 241-246, 1995.
197. KRAMER W, SAUBER K, BARINGHAUS KH, KURZ M, STENGELIN S, LANGE G, CORSIERO D, GIRBIG F, KONIG W, AND WEYLAND C. Identification of the bile acid-binding site of the ileal lipid-binding protein by photoaffinity labeling, matrix-assisted laser desorption ionization-mass spectrometry, and NMR structure. J Biol Chem 276: 7291-7301, 2001.
198. +/bile acid cotransporters of the rabbit. I. Transport studies with membrane vesicles and cell lines expressing the cloned transporters. J Lipid Res 40: 1604-1617, 1999.
199. +/bile-salt-cotransport system. Eur J Biochem 249: 456-464, 1997.
200. KTISTAKI E AND TALIANIDIS I. Modulation of hepatic gene expression by hepatocyte nuclear factor 1. Science 277: 109-113, 1997.
201. KUBITZ R, HUTH C, SCHMITT M, HORBACH A, KULLAK-UBLICK G, AND HAUSSINGER D. Protein kinase C-dependent distribution of the multidrug resistance protein 2 from the canalicular to the basolateral membrane in human HepG2 cells. Hepatology 34: 340-350, 2001.
202. KUBITZ R, WETTSTEIN M, WARSKULAT U, AND HAUSSINGER D. Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology 116: 401-410, 1999.
203. KULLAK-UBLICK GA. Regulation of organic anion and drug transporters of the sinusoidal membrane. J Hepatol 31: 563-573, 1999.
204. KULLAK-UBLICK GA, BEUERS U, FAHNEY C, HAGENBUCH B, MEIER PJ, AND PAUMGARTNER G. Identification and functional characterization of the promoter region of the human organic anion transporting polypeptide gene. Hepatology 26: 991-997, 1997.
205. KULLAK-UBLICK GA, BEUERS U, AND PAUMGARTNER G. Hepatobiliary transport. J Hepatol 32: 3-18, 2000.
206. KULLAK-UBLICK GA, GLASA J, BÖKER C, OSWALD M, GRÜTZNER U, HAGENBUCH B, STIEGER B, MEIER PJ, BEUERS U, KRAMER W, WESS G, AND PAUMGARTNER G. Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas. Gastroenterology 113: 1295-1305, 1997.
207. KULLAK-UBLICK GA, HAGENBUCH B, STIEGER B, SCHTEINGART CD, HOFMANN AF, WOLKOFF AW, AND MEIER PJ. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology 109: 1274-1282, 1995.
208. KULLAK-UBLICK GA, ISMAIR MG, STIEGER B, LANDMANN L, HUBER R, PIZZAGALLI F, FATTINGER K, MEIER PJ, AND HAGENBUCH B. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 120: 525-533, 2001.
209. KULLAK-UBLICK GA, KERB R, MULLHAUPT B, RENNER EL, PENGER A, BRINKMANN U, STIEGER B, AND MEIER PJ. A novel R432T mutation in the bile salt export pump gene (BSEP: ABCB11) is associated with recurrent intrahepatic cholestasis in an adolescent patient (Abstract). Hepatology 34: 216A, 2001.
210. KULLAK-UBLICK GA, STIEGER B, HAGENBUCH B, AND MEIER PJ. Hepatic transport of bile salts. Semin Liver Dis 20: 273-292, 2000.
211. KURZ AK, BLOCK C, GRAF D, DAHL SV, SCHLIESS F, AND HAUSSINGER D. Phosphoinositide 3-kinase-dependent ras activation by tauroursodesoxycholate in rat liver. Biochem J 350: 207-213, 2000.
212. KURZ AK, GRAF D, SCHMITT M, VOM DS, AND HAUSSINGER D. Tauroursodesoxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats. Gastroenterology 121: 407-419, 2001.
213. LAMMERT F, CAREY MC, AND PAIGEN B. Chromosomal organization of candidate genes involved in cholesterol gallstone formation: a murine gallstone map. Gastroenterology 120: 221-238, 2001.
214. LAMMERT F, COHEN DE, PAIGEN B, CAREY MC, AND BEIER DR. The gene encoding the multispecific organic anion transporter (Cmoat) of the hepatocyte canalicular membrane maps to mouse chromosome 19. Mamm Genome 9: 87-88, 1998.
215. LAYDEN TJ AND BOYER JL. Influence of bile acids on bile canalicular membrane morphology and the lobular gradient in canalicular size. Lab Invest 39: 110-119, 1978.
216. LAZARIDIS KN, PHAM L, TIETZ P, MARINELLI RA, DEGROEN PC, LEVINE S, DAWSON PA, AND LARUSSO NF. Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter. J Clin Invest 100: 2714-2721, 1997.
217. LAZARIDIS KN, TIETZ P, WU T, KIP S, DAWSON PA, AND LARUSSO NF. Alternative splicing of the rat sodium/bile acid transporter changes its cellular localization and transport properties. Proc Natl Acad Sci USA 97: 11092-11097, 2000.
218. LECUREUR V, SUN D, HARGROVE P, SCHUETZ EG, KIM RB, LAN LB, AND SCHUETZ JD. Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein. Mol Pharmacol 57: 24-35, 2000.
219. LEE J, AZZAROLI F, WANG L, SOROKA CJ, GIGLIOZZI A, SETCHELL KD, KRAMER W, AND BOYER JL. Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology 121: 1473-1484, 2001.
220. LEE J AND BOYER JL. Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders. Semin Liver Dis 20: 373-384, 2000.
221. LEE JM, TRAUNER M, SOROKA CJ, STIEGER B, MEIER PJ, AND BOYER JL. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 118: 163-172, 2000.
222. LEE MH, LU K, HAZARD S, YU H, SHULENIN S, HIDAKA H, KOJIMA H, ALLIKMETS R, SAKUMA N, PEGORARO R, SRIVASTAVA AK, SALEN G, DEAN M, AND PATEL SB. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 27: 79-83, 2001.
223. LEE YK, DELL H, DOWHAN DH, HADZOPOULOU-CLADARAS M, AND MOORE DD. The orphan nuclear receptor shp inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression. Mol Cell Biol 2000;20: 187-195, 2000.
224. LEKSTROM-HIMES J AND XANTHOPOULOS KG. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 273: 28545, 1998.
225. LESAGE G, GLASER S, AND ALPINI G. Regulation of cholangiocyte proliferation. Liver 21: 73-80, 2001.
226. LI D, ZIMMERMAN TL, THEVANANTHER S, LEE HY, KURIE JM, AND KARPEN SJ. Interleukin-1B-mediated suppression of RXR: RAR transactivation of the Ntcp promoter is JNK-dependent. J Biol Chem 277: 31416-31422, 2002.
227. 4 as a substrate for oatpl, the hepatic sinusoidal organic solute transporter. J Biol Chem 273: 16184-16191, 1998.
228. LI L, MEIER PJ, AND BALLATORI N. Oatp2 mediates bidirectional organic solute transport: a role for intracellular glutathione. Mol Pharmacol 58: 335-340, 2000.
229. LU K, LEE MH, YU H, ZHOU Y, SANDELL SA, SALEN G, AND PATEL SB. Molecular cloning, genomic organization, genetic variations and characteization of murine sterolin genes Abcg5 and Abcg8. J Lipid Res 43: 565-578, 2002.
230. LU TT, MAKISHIMA M, REPA JJ, SCHOONJANS K, KERR TA, AUWERX J, AND MANGELSDORF DJ. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6: 507-515, 2000.
231. LU TT, REPA JJ, AND MANGELSDORF DJ. Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. J Biol Chem 276: 37735-37738, 2001.
232. MACIAS RI, PASCUAL MJ, BRAVO A, ALCALDE MP, LARENA MG, ST SERRANO MA, AND MARIN JJ. Effect of maternal cholestasis on bile acid transfer across the rat placenta-maternal liver tandem. Hepatology 31: 975-983, 2000.
233. MADON J, HAGENBUCH B, LANDMANN L, MEIER PJ, AND STIEGER B. Transport function and hepatocellular localization of mrp6 in rat liver. Mol Pharmacol 57: 634-641, 2000.
234. MAKISHIMA M, LU TT, XIE W, WHITFIELD GK, DOMOTO H, EVANS RM, HAUSSLER MR, AND MANGELSDORF DJ. Vitamin D receptor as an intestinal bile acid sensor. Science 296: 1313-1316, 2002.
235. MAKISHIMA M, OKAMOTO AY, REPA JJ, TU H, LEARNED RM, LUK A, HULL MV, LUSTIG KD, MANGELSDORF DJ, AND SHAN B. Identification of a nuclear receptor for bile acids. Science 284: 1362-1365, 1999.
236. MANGELSDORF DJ AND EVANS RM. The RXR heterodimers and orphan receptors. Cell 83: 841-850, 1995.
237. MANGELSDORF DJ, THUMMEL C, BEATO M, HERRLICH P, SCHUTZ G, UMESONO K, BLUMBERG B, KASTNER P, MARK M, AND CHAMBON P. The nuclear receptor superfamily: the second decade. Cell 83: 835-839, 1995.
238. MARTINEZ-ANSO E, CASTILLO JE, DIEZ J, MEDINA JF, AND PRIETO J. Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver. Hepatology 19: 1400-1406, 1994.
239. MAUAD TH, VAN NIEUWKERK CMJ, DINGEMANS KP, SMIT JJM, SCHINKEL AH, NOTENBOOM RGE, VANDENBERGHWEERMAN MA, VERKRUISEN RP, GROEN AK, OUDE ELFERINK RPJ, VANDERVALK MA, BORST P, AND OFFERHAUS GJA. Mice with homozygous disruption of the mdr2 p-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am J Pathol 145: 1237-1245, 1994.
240. MAYER R, KARTENBECK J, BUCHLER M, JEDLITSCHKY G, LEIER I, AND KEPPLER D. Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes. J Cell Biol 131: 137-150, 1995.
241. MEIER PJ. Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile. Am J Physiol Gastrointest Liver Physiol 269: G801-G812, 1995.
242. MEIER PJ, ECKHARDT U, SCHROEDER A, HAGENBUCH B, AND STIEGER B. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. Hepatology 26: 1667-1677, 1997.
243. MEIER PJ, KNICKELBEIN RG, MOSELEY RH, DOBBINS JW, AND BOYER JL. Evidence for carrier-mediated chloride/bicarbonate exchange in canalicular rat liver plasma membrane vesicles. J Clin Invest 75: 1256-1263, 1985.
244. MEIER PJ AND STIEGER B. Molecular mechanisms in bile formation. News Physiol Sci 15: 89-93, 2000.
245. MEIER PJ AND STIEGER B. Bile salt transporters. Annu Rev Physiol 64: 635-661, 2002.
246. MEKHJIAN HS, PHILLIPS SF, AND HOFMANN AF. Colonic absorption of unconjugated bile acids: perfusion studies in man. Dig Dis Sci 24: 545-550, 1979.
247. MENG LJ, WANG P, WOLKOFF AW, KIM RB, TIRONA RG, HOFMANN AF, AND PANG KS. Transport of the sulfated, amidated bile acid, sulfolithocholyltaurine, into rat hepatocytes is mediated by Oatp1 and Oatp2. Hepatology 35: 1031-1040, 2002.
248. MISRA S, UJHAZY P, GATMAITAN Z, VARTICOVSKI L, AND ARIAS IM. The role of phosphoinositide 3-kinase in taurocholate-induced trafficking of ATP-dependent canalicular transporters in rat liver. J Biol Chem 273: 26638-26644, 1998.
249. MISRA S, UJHAZY P, VARTICOVSKI L, AND ARIAS IM. Phosphoinositide 3-kinase lipid products regulate ATP-dependent transport by sister of P-glycoprotein and multidrug resistance associated protein 2 in bile canalicular membrane vesicles. Proc Natl Acad Sci USA 96: 5814-5819, 1999.
250. MITIC LL AND ANDERSON JM. Moleclar architecture of tight junctions. Annu Rev Physiol 60: 121-142, 1998.
251. MITIC LL, VAN ITALLIE CM, AND ANDERSON JM. Molecular physiology and pathophysiology of tight junctions. I. Tight junction structure and function: lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol 279: G250-G254, 2000.
252. MIYAKE JH, WANG SL, AND DAVIS RA. Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7alpha-hydroxylase. J Biol Chem 275: 21805-21808, 2000.
253. MIYATA M, KUDO G, LEE YH, YANG TJ, GELBOIN HV, FERNANDEZ-SALGUERO P, KIMURA S, AND GONZALEZ FJ. Targeted disruption of the microsomal epoxide hydrolast gene. J Biol Chem 274: 23963-23968, 1999.
254. +-taurocholate cotransport by translocating transporter to plasma membranes. Am J Physiol Gastrointest Liver Physiol 273: G842-G848, 1997.
255. +/taurocholate cotransport. J Biol Chem 273: 30039-30045, 1998.
256. MULLER M. Transcriptional control of hepatocanalicular transporter gene expression. Semin Liver Dis 20: 323-337, 2000.
257. MULLER M AND JANSEN PLM. Molecular aspects of hepatobiliary transport. Am J Physiol Gastrointest Liver Physiol 272: G1285-G1303, 1997.
258. MULLER M AND JANSEN PLM. The secretory function of the liver: new aspects of hepatobiliary transport. J Hepatol 28: 344-354, 1998.
259. NAKAGAWA M AND SETCHELL KD. Bile acid metabolism in early life: studies of amniotic fluid. J Lipid Res 31: 1089-1098, 1990.
260. NAKATSUKASA H, SILVERMAN JA, GANT TW, EVARTS RP, AND THORGEIRSSON SS. Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication. Hepatology 18: 1202-1207, 1993.
261. NATHANSON MH AND BOYER JL. Mechanisms and regulation of bile secretion. Hepatology 14: 551-566, 1991.
262. NOE B, HAGENBUCH B, STIEGER B, AND MEIER PJ. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. Proc Natl Acad Sci USA 94: 10346-10350, 1997.
263. NOE J, HAGENBUCH B, MEIER PJ, AND ST-PIERRE MV. Characterization of the mouse bile salt export pump overexpressed in the baculovirus system. Hepatology 33: 1223-1231, 2001.
264. NOE J, STEIGER B, AND MEIER P. Functional expression of the canalicular bile salt export pump (BSEP) of human liver. Gastro 123: 1659-1666, 2002.
265. NOZAWA S, MIYAZAKI M, TOU HI, NAKAGAWA KN, AMBIRU S, SHIMIZU H, KATO A, YOSHITOMI H, KAWAKI J, AND NAKAJIMA N. Human MDR1 and MDR3 gene expression in the liver with obstructive jaundice (Abstract). Gastroenterology 112: A1349, 1997.
266. OELKERS P, KIRBY LC, HEUBI JE, AND DAWSON PA. Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). J Clin Invest 99: 1880-1887, 1997.
267. OGAWA K, SUZUKI H, HIROHASHI T, ISHIKAWA T, MEIER PJ, HIROSE K, AKIZAWA T, YOSHIOKA M, AND SUGIYAMA Y. Characterization of inducible nature of MRP3 in rat liver. Am J Physiol Gastrointest Liver Physiol 278: G438-G446, 2000.
268. OHATA M, LIN M, SATRE M, AND TSUKAMOTO H. Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. Am J Physiol Gastrointest Liver Physiol 272: G589-G596, 1997.
269. OSWALD M, KULLAK-UBLICK GA, PAUMGARTNER G, AND BEUERS U. Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis. Liver 21: 247-253, 2001.
270. OTT P AND WEISIGER RA. Nontraditional effects of protein binding and hematocrit on uptake of indocyanine green by perfused rat liver. Am J Physiol Gastrointest Liver Physiol 273: G227-G238, 1997.
271. OUDE ELFERINK RPJ AND GROEN AK. Mechanisms of biliary lipid secretion and their role in lipid homeostasis. Semin Liver Dis 20: 293-305, 2000.
272. OUDE ELFERINK RPJ AND GROEN AK. Genetic defects in hepatobiliary transport. Biochim Biophys Acta 1586: 129-145, 2002.
273. OUDE ELFERINK RPJ AND JANSEN PL. The role of the canalicular multispecific organic anion transporter in the disposal of endo- and xenobiotics. Pharmacol Ther 64: 77-97, 1994.
274. OUDE ELFERINK RPJ, OTTENHOFF R, VAN MARLE J, FRIJTERS CMG, SMITH AJ, AND GROEN AK. Class III P-glycoproteins mediate the formation of lipoprotein X in the mouse. J Clin Invest 102: 1749-1757, 1998.
275. OUDE ELFERINK RPJ AND VAN BERGE HENEGOUWEN GP. Cracking the genetic code for benign recurrent and progressive familial intrahepatic cholestasis. J Hepatol 29: 317-320, 1998.
276. PARKS DJ, BLANCHARD SG, BLEDSOE RK, CHANDRA G, CONSLER TG, KLIEWER SA, STIMMEL B, WILLSON TM, ZAVACKI AM, MOORE DD, AND LEHMANN JM. Bile acids: natural ligands for an orphan nuclear receptor. Science 284: 1365-1368, 1999.
277. PAULUSMA C, KOTHE MJC, BAKKER CTM, BOSMA PJ, VAN BOKHOVEN I, VAN MARLE J, BOLDER U, TYTGAT GNJ, AND OUDE ELFERINK RPJ. Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver. Hepatology 31: 684-693, 2000.
278. PAULUSMA C, VAN GEER M, EVERS R, HEIJN M, OTTENHOFF R, BORST P, AND OUDE ELFERINK RPJ. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J 338: 393-401, 1999.
279. PAULUSMA CC, BOSMA PJ, ZAMAN GJR, BAKKER CTM, OTTER M, SCHEFFER GL, SCHEPER RJ, BORST P, AND OUDE ELFERINK RPJ. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271: 1126-1128, 1996.
280. PAULUSMA CC AND OUDE ELFERINK RPJ. The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man. J Mol Med 75: 420-428, 1997.
281. PAULUSMA CC, KOOL M, BOSMA PJ, SCHEFFER GL, TERBORG F, SCHEPER RJ, TYTGAT GNJ, BORST P, BAAS F, AND OUDE ELFERINK RPJ. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 25: 1539-1542, 1997.
282. PAWLIKOWSKA L, OTTENHOFF R, LOOIJE N, EPPENS EF, KNISELY AS, BULL L, KILLEEN NP, OUDE ELFERINK RPJ, AND FREIMER NB. FIC1 mutant mice have a defect in the regulation of intestinal bile salt absorption (Abstract). Hepatology 34: 240A, 2001.
283. PEI QL, KOBAYASHI Y, TANAKA Y, TAGUCHI Y, HIGUCHI K, KAITO M, MA N, SEMBA R, KAMISAKO T, AND ADACHI Y. Increased expression of multidrug resistance-associated protein 1 (mrp1) in hepatocyte basolateral membrane and renal tubular epithelia after bile duct ligation in rats. Hepatol Res 22: 58-64, 2002.
284. PHILLIPS MJ, POUCELL S, AND ODA M. Mechanisms of cholestasis. Lab Invest 54: 593-608, 1986.
285. PLASS JRM, MOL O, HEEGSMA J, GEUKEN M, FABER KN, JANSEN PLM, AND MULLER M. Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Hepatology 35: 589-596, 2002.
286. POLI V AND CILIBERTO G. Transcriptional regulation of acute phase genes by IL-6 and related cytokines. In: Liver Gene Expression, edited by Trouche F and Yaniv M. Austin, TX: Landes, 1994, p. 131-151.
287. RADOMINSKA-PYREK A, ZIMNIAK P, IRSHAID YM, LESTER R, TEPHLY TR, AND ST PYREK J. Glucuronidation of 6 alpha-hydroxy bile acids by human liver microsomes. J Clin Invest 80: 234-241, 1987.
288. RAEDSCH R, LAUTERBURG BH, AND HOFMANN AF. Altered bile acid metabolism in primary biliary cirrhosis. Dig Dis Sci 26: 394-401, 1981.
289. RAUSA FM, TAN Y, ZHOU H, YOO KW, STOLZ DB, WATKINS SC, FRANKS RR, UNTERMAN TG, AND COSTA RH. Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis. Mol Cell Biol 20: 8264-8282, 2000.
290. REICHEL C, GAO B, VAN MONTFOORT J, CATTORI V, RAHNER C, HAGENBUCH B, STIEGER B, KAMISAKO T, AND MEIER PJ. Localization and function of the organic anion-transporting polypeptide oatp2 in rat liver. Gastroenterology 117: 688-695, 1999.
291. REICHEN J. The role of the sinusoidal endothelium in liver function. News Physiol Sci 14: 117-121, 1999.
292. RINGPFEIL F, LEBWOHL MG, CHRISTIANO AM, AND UITTO J. Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABD) transporter. Proc Natl Acad Sci USA 97: 6001-6006, 2000.
293. RIPPIN SJ, HAGENBUCH B, MEIER PJ, AND STIEGER B. Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes. Hepatology 33: 776-782, 2001.
294. ROELOFSEN H, SOROKA C, DIETRICH K, AND BOYER JL. Cyclic AMP stimulates sorting of the canalicular organic anion transporter (Mrp2/cMoat) to the apical domain in hepatocyte couplets. J Cell Sci 111: 1137-1145, 1998.
295. ROS JE, SCHUETZ JD, GEUKEN M, STREETZ K, MOSHAGE H, KUIPERS F, MANNS MP, JANSEN PL, TRAUTWEIN C, AND MULLER M. Induction of Mdr1b expression by tumor necrosis factor-alpha in rat liver cells is independent of p53 but requires NF-kappaB signaling. Hepatology 33: 1425-1431, 2001.
296. ROST D, KARTENBECK J, AND KEPPLER D. Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin-induced cholestasis. Hepatology 29: 814-821, 1999.
297. ROST D, KONIG J, WEISS G, KLAR E, STREMMEL W, AND KEPPLER D. Expression and localization of the multidrug resistance proteins mrp2 and mrp3 in human gallbladder epithelia. Gastroenterology 121: 1203-1208, 2001.
298. ROST D, MAHNER S, SUGIYAMA Y, AND STREMMEL W. Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine. Am J Physiol Gastrointest Liver Physiol 282: G720-G726, 2002.
299. RUST S, ROSIER M, FUNKE H, REAL J, AMOURA Z, PIETTE JC, DELEUZE JF, BREWER HB, DUVERGER N, DENEFLE P, AND ASSMANN G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22: 352-355, 1999.
300. SAEKI T, MATOBA K, FURUKAWA H, KIRIFUJI K, KANAMOTO R, AND IWAMI K. Characterization, cDNA cloning, and functional expression of mouse ileal sodium-dependent bile acid transporter. J Biochem (Tokyo) 125: 846-851, 1999.
301. - exchange. J Biol Chem 272: 26340-26345, 1997.
302. SAUER P, STIEHL A, FITSCHER BA, HANS-DIETER R, BENZ C, KLÖTERS-PLACHKY P, STENGELIN S, STREMMEL W, AND KRAMER W. Downregulation of ileal bile acid absorption in bile-duct-ligated rats. J Hepatol 33: 2-8, 2000.
303. SCHAUB TP, KARTENBECK J, KONIG J, SPRING H, DORSAM J, STAEHLER G, STORKEL S, THON WF, AND KEPPLER D. Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. J Am Soc Nephrol 10: 1159-1169, 1999.
304. SCHAUB TP, KARTENBECK J, KONIG J, VOGEL O, WITZGALL R, KRIZ W, AND KEPPLER D. Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J Am Soc Nephrol 8: 1213-1221, 1997.
305. SCHEFFER GL, KOOL M, DE HAAS M, DE VREE JM, PIJNENBORG AC, BOSMAN DK, ELFERINK RP, VAN D V, BORST P, AND SCHEPER RJ. Tissue distribution and induction of human multidrug resistant protein 3. Lab Invest 82: 193-201, 2002.
306. SCHLIESS F, KURZ AK, VOM DAHL S, AND HÄUSSINGER D. Mitogen-activated protein kinases mediate the stimulation of bile acid secretion by tauroursodeoxycholate in rat liver. Gastroenterology 113: 1306-1314, 1997.
307. SCHMITT M, KUBITZ R, WETTSTEIN M, VOM DS, AND HAUSSINGER D. Retrieval of the mrp2 gene encoded conjugate export pump from the canalicular membrane contributes to cholestasis induced by tert-butyl hydroperoxide and chloro-dinitrobenzene. J Biol Chem 381: 487-495, 2000.
308. SCHOONJANS K AND AUWERX J. A sharper image of SHP. Nat Med 8: 789-791, 2002.
309. SCHRENK D, BAUS PR, ERMEL N, KLEIN C, VORDERSTEMANN B, AND KAUFFMANN HM. Up-regulation of transporters of the MRP family by drugs and toxins. Toxicol Lett 120: 51-57, 2001.
310. SCHRENK D, GANT TW, PREISEGGER KH, SILVERMAN JA, MARINO PA, AND THORGEIRSSON SS. Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. Hepatology 17: 854-860, 1993.
311. SCHUETZ EG, STROM S, YASUDA K, LECUREUR V, ASSEM M, BRIMER C, LAMBA J, KIM RB, RAMACHANDRAN V, KOMOROSKI BJ, VENKATARAMANAN R, CAI H, SINAL CJ, GONZALEZ FJ, AND SCHUETZ JD. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem 276: 39411-39418, 2001.
312. SERRANO MA, BRITES D, LARENA MG, MONTE MJ, BRAVO MP, OLIVEIRA N, AND MARIN JJG. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta. J Hepatol 28: 829-839, 1998.
313. SETCHELL KDR, RODRIGUES CMP, CLERICI C, SOLINAS A, MORELLI A, GARTUNG
314. SHIAO T, IWAHASHI M, FORTUNE J, QUATTROCHI L, BOWMAN S, WICK M, QADRI I, AND SIMON FR. Structural and functional characterization of liver cell-specific activity of the human sodium/taurocholate cotransporter. Genomics 69: 203-213, 2000.
315. SHIH DQ, BUSSEN M, SEHAYEK E, ANANTHANARAYANAN M, SHNEIDER BL, SUCHY FJ, SHEFER S, BOLLILENI JS, GONZALEZ FJ, BRESLOW JL, AND STOFFEL M. Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet 27: 375-382, 2001.
316. SHIH DQ, BUSSEN M, SEHAYEK E, ANANTHANARAYANAN M, SHNEIDER BL, SUCHY FJ, SHEFER S, BOLLILENI JS, GONZALEZ FJ, BRESLOW JL, AND STOFFEL M. HNF-1 alpha: have bile acid transport genes found their "master"? J Hepatol 36: 142-145, 2002.
317. SHNEIDER BL, DAWSON PA CHRISTIE DM, HARDIKAR W, WONG MH, AND SUCHY FJ. Cloning and molecular characterization of the ontogency of a rat ileal sodium-dependent bile acid transporter. J Clin Invest 95: 745-762, 1995.
318. SHNEIDER BL, FOX VL, SCHWARZ KB, WATSON CL, ANANTHANARAYANAN M, THEVANANTHER S, CHRISTIE DM, HARDIKAR W, SETCHELL KDR, MEILI-VERGANI G, SUCHY FJ, AND MOWAT AP. Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic biliary atresia. Hepatology 25: 1176-1183, 1997.
319. SHNEIDER BL, SETCHELL KD, AND CROSSMAN MW. Fetal and neonatal expression of the apical sodium-dependent bile acid transporter in the rat ileum and kidney. Pediatr Res 42: 189-194, 1997.
320. SHODA J, KANO M, ODA K, KAMIYA J, NIMURA Y, SUZUKI H, SUGIYAMA Y, MIYAZAKI H, TODOROKI T, STENGELIN S, KRAMER W, MATSUZAKI Y, AND TANAKA N. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function. Am J Gastroenterol 96: 3368-3378, 2001.
321. SHODA J, ODA K, SUZUKI H, SUGIYAMA Y, ITO K, COHEN DE, FENG L, KAMIYA J, NIMURA Y, MIYAZAKI H, KANO M, MATSUZAKI Y, AND TANAKA N. Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi. Hepatology 33: 1194-1205, 2001.
322. SIMON FR, FORTUNE J, IWAHASHI M, GARTUNG C, WOLKOFF A, AND SUTHERLAND E. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am J Physiol Gastrointest Liver Physiol 271: G1043-G1052, 1996.
323. SINAL CJ, TOHKIN M, MIYATA M, WARD JM, LAMBERT G, AND GONZALEZ FJ. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102: 731-744, 2000.
324. SMIT JJ, SCHINKEL AH, OUDE ELFERINK RPJ, GROEN AK, WAGENAAR E, VENDEEMTER L, MOL CA, OTTENHOFF R, VANDERLUGT NM, AND VANROOM MA. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75: 451-462, 1993.
325. SMIT JW, SCHINKEL AH, MULLER M, WEERT B, AND MEIJER DKF. Contribution of the murine mdrla P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with an mdrla gene disruption. Hepatology 27: 1056-1063, 1998.
326. SMITH AJ, DE VREE JML, OTTENHOFF R, OUDE ELFERINK RPJ, SCHINKEL AH, AND BORST P. Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (-/-). Hepatology 28: 530-536, 1998.
327. SOROKA CJ, CAI SY, AND BOYER JL. Effects of cholestasis on the regulation of membrane transporter expression in intestine and kidney (Abstract). Hepatology 36: 462A, 2002.
328. SOROKA CJ, LEE JM, AZZAROLI F, AND BOYER JL. Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 33: 783-791, 2001.
329. SPERBER I. Secretion of organic anions in the formation of urine and bile. Pharmacol Rev 11: 109-134, 1959.
330. STAUDINGER J, LIU Y, MADAN A, HABEEBU S, AND KLAASSEN CD. Coor dinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab Dispos 29: 1467-1472, 2001.
331. STAUDINGER JL, GOODWIN B, JONES SA, HAWKINS-BROWN D, MACKENZIE KI, LATOUR A, LIU Y, KLAASSEN CD, BROWN KK, REINHARD J, WILLSON TM, KOLLER BH, AND KLIEWER SA. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 98: 3369-3374, 2001.
332. STIEGER B. FIC1: another bile salt carrier within the enterohepatic circulation? J Hepatol 35: 522-524, 2001.
333. STIEGER B, FATTINGER K, MADON J, KULLAK-UBLICK GA, AND MEIER PJ. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 118: 422-430, 2000.
334. +/taurocholate cotransporting polypeptide in rat liver. Gastroenterology 107: 1781-1787, 1994.
335. STIEHL A, Bile salt sulphates in cholestasis. Eur J Clin Invest 4: 59-63, 1974.
336. STIEHL A, RAEDSCH R, RUDOLPH G, GUNDERT-REMY U, AND SENN M. Biliary and urinary excretion of sulfated, glucuronidated and tetrahydroxylated bile acids in cirrhotic patients. Hepatology 5: 492-495, 1985.
337. STOCKEL B, KONIG J, NIES AT, CUI Y, BROM M, AND KEPPLER D. Characterization of the 5′-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation compared with the multidrug resistance protein 3 (MRP3) gene. Eur J Biochem 267: 1347-1358, 2000.
338. ST-PIERRE MV, HAGENBUCH B, UGELE B, MEIER PJ, AND STALLMACH T. Characterization of an organic anion-transporting polypeptide (OATP-B) in human placenta. J Clin Endocrinol Metab 87: 1856-1863, 2002.
339. ST-PIERRE MV, KULLAK-UBLICK GA, HAGENBUCH B, AND MEIER PJ. Transport of bile acids in hepatic and non-hepatic tissues. J Exp Biol 204: 1673-1686, 2001.
340. ST-PIERRE MV, SERRANO MA, MACIAS RI, DUBS U, HOECHLI M, LAUPER U, MEIER PJ, AND MARIN JJ. Expression of members of the multidrug resistance protein family in human term placenta. Am J Physiol Regul Integr Comp Physiol 279: R1495-R1503, 2000.
341. STRAUTNIEKS SS, BULL LN, KNISELY AS, KOCOSHIS SA, DAHL N, ARNELL H, SOKAL E, DAHAN K, CHILDS S, LING V, TANNER MS, KAGALWALLA AF, NEMETH A, PAWLOWSKA J, BAKER A, MIELI-VERGANI G, FREIMER NB, GARDINER RM, AND THOMPSON RJ. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic Cholestasis. Nat Genet 20: 233-238, 1998.
342. STURM E, ZIMMERMAN TL, DENSON LA, KARPEN SJ, AND CRAWFORD JM. Retinoids upregulate bile acid uptake in primary rat hepatocytes and in a hepatocyte cell line (Abstract). Hepatology 30: 466A, 1999.
343. SUEYOSHI T AND NEGISHI M. Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu Rev Pharmacol Toxicol 41: 123-143, 2001.
344. +/bile acid cotransporter: importance of the cytoplasmic tail to function and plasma membrane targeting. J Biol Chem 276: 6825-6833, 2001.
345. SUZUKI H AND SUGIYAMA Y. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur J Pharm Sci 12: 3-12, 2000.
346. SUZUKI H AND SUGIYAMA Y. Transport of drugs across the hepatic sinusoidal membrane: sinusoidal drug influx and efflux in the liver. Semin Liver Dis 20: 251-263, 2000.
347. SYNOLD TW, DUSSAULT I, AND FORMAN BM. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med 7: 584-590, 2001.
348. TAMAI I, NOZAWA T, KOSHIDA M, NEZU J, SAI Y, AND TSUJI A. Functional characterization of human organic anion transporting polypeptide B (OATP-B) compared with liver-specific OATP-C. Pharm Res 18: 1262-1269, 2001.
349. TANAKA Y, KOBAYASHI Y, GABAZZA EC, HIGUCHI K, KAMISAKO T, KURODA M, TAKEUCHI K, IWASA M, KAITO M, AND ADACHI Y. Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice. Am J Physiol Gastrointest Liver Physiol 282: G656-G662, 2002.
350. TANIGUCHI K, WADA M, KOHNO K, NAKAMURA T, KAWABE T, KAWAKAMI M, KAGOTANI K, OKUMURA K, AKIYAMA S, AND KUWANO M. A human canalicular multispecific organic anion transporter (cMoat) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res 56: 4124-4129, 1996.
351. TIRONA RG, LEAKE BF, MERINO G, AND KIM RB. Polymorphisms in OATP-C. Identification of multiple allelic variants associated with altered transport activity among european- and african-americans. J Biol Chem 276: 35669-35675, 2001.
352. TOMIDA S, ABEL M, YAMAGUCHI T, MATSUZAKI Y, SHODA J, TANAKA N, AND OSUGA T. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis. Hepatology 30: 6-13, 1999.
353. TRAUNER M, ARRESE M, LEE H, BOYER JL, AND KARPEN S. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest 101: 2092-2100, 1998.
354. TRAUNER M, ARRESE M, SOROKA C, ANANTHANARAYANAN M, KOEPPEL TA, SCHLOSSER SF, SUCHY FJ, KEPPLER D, AND BOYER JL. The rat canalicular conjugate export pump (mrp 2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 113: 255-264, 1997.
355. TRAUNER M, MEIER PJ, AND BOYER JL. Molecular pathogenesis of cholestasis. N Engl J Med 339: 1217-1227, 1998.
356. TRAUNER M, MEIER PJ, AND BOYER JL. Molecular regulation of hepatocellular transport systems in cholestasis. J Hepatol 31: 165-178, 1999.
357. TRONCHE F, BACH I, DAVID-WATTINE TCB, PONTOGLIO M, SOURDIVE FRD, THÉPOT D, AND YANIV M. Hepatocyte nuclear factor 1 (HNF1) and liver gene expression. In: Liver Gene Expression, edited by Tronche F and Yaniv M. Austin, TX: Landes, 1994, p. 155-181.
358. UJHAZY P, ORTIZ D, MISRA S, LI S, MOSELEY J, JONES H, AND ARIAS IM. Familial intrahepatic cholestasis 1: studies of localization and function. Hepatology 34: 768-775, 2001.
359. VAN DER BLIEK AM, KOOIMAN PM, SCHNEIDER C, AND BORST P. Sequence of mdr3 cDNA encoding a human P-glycoprotein. Gene 71: 401-411, 1988.
360. VAN KUIJCK MA, KOOL M, MERKX GF, GEURTS VK, BINDELS RJ, DEEN PM, AND VAN OS CH. Assignment of the canalicular multispecific organic anion transporter gene (CMOAT) to human chromosome 10q24 and mouse chromosome 19D2 by fluorescent in situ hybridization. Cytogenet Cell Genet 77: 285-287, 1997.
361. VAN MIL SW, KLOMP LW, BULL LN, AND HOUWEN RH. FIC1 disease: a spectrum of intrahepatic cholestatic disorders. Semin Liver Dis 21: 535-544, 2001.
362. +-dependent bile acid transport by hepatocytes is mediated by a protein similar to microsomal epoxide hydrolase. Am J Physiol Gastrointest Liver Physiol 264: G528-G534, 1993.
363. VONDIPPE P, AMOUI M, STELLWAGEN RH, AND LEVY D. The functional expression of sodium-dependent bile acid transport in Madin-Darby canine kidney cells transfected with the cDNA for microsomal epoxide hydrolase. J Biol Chem 271: 18176-18180, 1996.
364. VOS TA, HOOIVELD GJ, KONING H, CHILDS S, MEIJER DK, MOSHAGE H, JANSEN PL, AND MULLER M. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 28: 1637-1644, 1998.
365. VOS TA, ROS JE, HAVINGA R, MOSHAGE H, KUIPERS F, JANSEN PL, AND MULLER M. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats. Hepatology 29: 1833-1839, 1999.
366. WADA M, TOH S, TANIGUCHI K, NAKAMURA T, UCHIUMI T, KOHNO K, YOSHIDA I, KIMURA A, SAKISAKA S, ADACHI Y, AND KUWANO M. Mutations in the canalicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. Hum Mol Genet 7: 203-207, 1998.
367. WALTERS HC, CRADDOCK AL, FUSEGAWA H, WILLINGHAM MC, AND DAWSON PA. Expression, transport properties, and chromosomal location of organic anion transporter subtype 3. Am J Physiol Gastrointest Liver Physiol 279: G1188-G1200, 2000.
368. WAN YJ, AN D, CAI Y, REPA JJ, HUNG-PO CT, FLORES M, POSTIC C, MAGNUSON MA, CHEN J, CHIEN KR, FRENCH S, MANGELSDORF DJ, AND SUCOV HM. Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol Cell Biol 20: 4436-4444, 2000.
369. WANG B, CAI SR, GAO C, SLADEK FM, AND PONDER KP. Lipopolysaccharide results in a marked decrease in hepatocyte nuclear factor 4alpha in rat liver. Hepatology 34: 979-989, 2001.
370. WANG H, CHEN J, HOLLISTER K, SOWERS LC, AND FORMAN BM. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 3: 543-553, 1999.
371. WANG L, LEE YK, BUNDMAN D, HAN Y, THEVANANTHER S, KIM CS, CHUA SS, WEI P, HEYMAN RA, KARIN M, AND MOORE DD. Redundant pathways for negative feedback regulation of bile acid production. Dev Cell 2: 721-731, 2002.
372. WANG L, SOROKA CJ, AND BOYER JL. The role of bile salt export pump mutations in progressive familial intahepatic cholestasis type II. J Clin Invest 110: 965-972, 2002.
373. WANG R, SALEM M, YOUSEF IM, TUCHWEBER B, LAM P, CHILDS SJ, HELGASON CD, ACKERLEY C, PHILLIPS MJ, AND LING V. Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in non-progressive but persistent intrahepatic cholestasis. Proc Natl Acad Sci USA 98: 2011-2016, 2001.
374. WAXMAN DJ. P450 gene induction by structurally diverse xenochemicals: cental role of nuclear receptors CAR, PXR and PPAR. Arch Biochem Biophys 369: 11-23, 1999.
375. WEBSTER CR AND ANWER MS. Role of the PI3K/PKB signaling pathway in cAMP-mediated translocation of rat liver Ntcp. Am J Physiol Gastrointest Liver Physiol 277: G1165-G1172, 1999.
376. +/taurocholate cotransport and Ntcp translocation (Abstract). J Biol Chem 277: 28578-28583, 2002.
377. WEI P, ZHANG J, EGAN-HAFLEY M, LIANG S, AND MOORE DD. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 407: 920-923, 2000.
378. WEINBERG SL, BURCKHARDT G, AND WILSON FA. Taurocholate transport by rat intestinal basolateral membrane vesicles. J Clin Invest 78: 44-50, 1986.
379. WEISIGER RA. Dissociation from albumin: a potentially rate-limiting step in the clearance of substances by the liver. Proc Natl Acad Sci USA 85: 1563-1567, 1985.
380. WEISIGER RA, ZACKS CM, SMITH ND, AND BOYER JL. Effect of albumin binding on extraction of sulfobromophthalein by perfused elasmobranch liver: evidence for dissociation-limited uptake. Hepatology 4: 492-501, 1984.
381. WIELANDT AM, VOLLRATH V, MANZANO M, MIRANDA S, ACCATINO L, AND CHIANALE J. Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5-trichlorophenoxyacetic acid in the mouse liver. Biochem J 341: 105-111, 1999.
382. WIETHOLTZ H, MARSCHALL HU, SJOVALL J, AND MATERN S. Stimulation of bile acid 6 alpha-hydroxylation by rifampin. J Hepatol 24: 713-718, 1996.
383. WILSON FA, BURCKHARDT G, MURER H, RUMRICH G, AND ULLRICH KJ. Sodium-coupled taurocholate transport in the proximal convolution of the rat kidney in vivo and in vitro. J Clin Invest 67: 1141-1150, 1981.
384. WONG MH, OELKERS P, CRADDOCK AL, AND DAWSON PA. Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter. J Biol Chem 269: 1340-1347, 1994.
385. WONG MH, OELKERS P, AND DAWSON PA. Identification of a mutation in the ileal sodium-dependent bile acid transporter gene that abolishes transport activity. J Biol Chem 270: 27228-27234, 1995.
386. WRIGHT EM, HAGER KM, AND TURK E. Sodium cotransport proteins. Curr Opin Cell Biol 4: 696-702, 1992.
387. XIE W, BARWICK JL, DOWNES M, BLUMBERG B, SIMON CM, NELSON MC, NEUSCHWANDER-TETRI BA, BRUNT EM, GUZELIAN PS, AND EVANS RM. Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 406: 435-439, 2000.
388. XIE W, BARWICK JL, SIMON CM, PIERCE AM, SAFE S, BLUMBERG B, GUZELIAN PS, AND EVANS RM. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev 14: 3014-3023, 2000.
389. XIE W AND EVANS RM. Orphan nuclear receptors: the exotics of xenobiotics. J Biol Chem 276: 37739-37742, 2001.
390. XIE W, RADOMINSKA-PANDYA A, SHI Y, SIMON CM, NELSON MC, ONG ES, WAXMAN DJ, AND EVANS RM. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA 98: 3375-3380, 2001.
391. YANG Y, ZHANG M, EGGERTSEN G, AND CHIANG JYL. On the mechanism of bile acid inhibition of rat sterol 12α-hydroxylase gene (CYP8B1) transcription: roles of α-fetoprotein transcription factor and hepatocyte nuclear factor 4α. Biochim Biophys Acta 1583: 63-73, 2002.
392. YEH H, SCHTEINGART CD, HAGEY LR, TON-NU H, BOLDER U, GAVRILKINA MA, STEINBACH JH, AND HOFMANN AF. Effect of side chain length on biotransformation, hepatic transport and choleretic properties of chenodeoxycholyl homologues in the rodent: studies with dinochenodeoxycholic acid, norchenodeoxycholic acid and chenodeoxycholic acid. Hepatology 26: 374-385, 1997.
393. Yu J, Lo JL, HUANG L, ZHAO A, METZGER E, ADAMS A, MEINKE PT, WRIGHT SD, AND CUI J. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. J Biol Chem 277: 31441-31447, 2002.
394. Yu L, LI-HAWKINS J, HAMMER RE, BERGE KE, HORTON JD, COHEN JC, AND HOBBS HH. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 110: 671-680, 2002.
395. ZENG H, LIU G, REA PA, AND KRUH GD. Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res 60: 4779-4784, 2000.
396. ZHU QS, VON DIPPE P, XING W, AND LEVY D. Membrane topology and cell surface targeting of microsomal epoxide hydrolase. J Biol Chem 274: 27898-27904, 1999.
397. ZINCHUK VS, OKADA T, AKIMARU K, AND SEGUCHI H. Asynchronous expression and colocalization of Bsep and Mrp2 during development of rat liver. Am J Physiol Gastrointest Liver Physiol 282: G540-G548, 2002.
398. ZOLLNER G, FICKERT P, SILBERT D, FUCHSBICHLER A, STUMPTNER C, NEUBERGER J, ZATLOUKAL K, DENK H, AND TRAUNER M. Alterations of hepatobiliary transporter expression in primary biliary cirrhosis (PBC) (Abstract). J Hepatol 36: 87, 2002.
399. ZOLLNER G, FICKERT P, SILBERT D, FUCHSBICHLER A, STUMPTNER C, ZATLOUKAL K, DENK H, AND TRAUNER M. Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile ductligated mice. Am J Physiol Gastrointest Liver Physiol 282: G184-G191, 2002.
400. ZOLLNER G, FICKERT P, ZENZ R, FUCHSBICHLER A, STUMPTNER C, KENNER L, FERENCI P, STAUBER RE, KREJS GJ, DENK H, ZATLOUKAL K, AND TRAUNER M. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 33: 633-646, 2001.